ArticleMikrochimica acta2026
Aptamer-based fluorescence "off-on" sensor for EGFR-positive lung cancer CTCs using streptavidin magnetic beads and N-CQDs@Ag⁺.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Circulating tumor cells (CTCs) are rare but critical biomarkers for lung cancer diagnosis and metastasis monitoring. We report an aptamer-based fluorescence "off-on" sensor for the sensitive and specific detection of epidermal growth factor receptor (EGFR)-positive lung cancer CTCs. The sensor integrates streptavidin magnetic beads (MBs) for target capture and nitrogen-doped carbon quantum dots complexed with silver ions (N-CQDs@Ag⁺) for signal readout. In the absence of target cells, the system remains in a fluorescence "off" state due to efficient quenching by Ag⁺. Upon recognition of EGFR-positive CTCs by the biotinylated aptamer, a complementary S2 strand containing a polyC sequence is released and competitively binds Ag⁺, restoring the fluorescence of N-CQDs ("on" state). Under optimal conditions, the sensor achieves a detection limit of 50 cells/mL in buffer and 96 cells/mL in human serum, with excellent selectivity. This aptamer-based off-on sensor provides a simple and reliable platform for lung cancer CTC detection.
Indexed as
Identifiers
42446745What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.